Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study.
Ju Yeon KimMiso KimJin Kyun ParkEun Bong LeeJun Won ParkJunshik HongPublished in: Orphanet journal of rare diseases (2022)
Our results suggest that tocilizumab has limited efficacy in treating adult patients with sHLH and could increase the risk of infectious complications compared to the conventional treatments.